ADVERSE REACTIONS

Tadalafil > tadalafil 40mg


Avoid concomitant use of tucatinib with CYP3A substrates, where minimal concentration changes may lead to serious or life-threatening toxicities.

  • Tadalafil 40mg may require dose adjustments based on response.
  • The medication can interact with blood thinners regarding bleeding risk.
  • Regular health check-ups are recommended while using Tadalafil 40mg.
  • Do not take Tadalafil 40mg if you are using recreational drugs.
  • Women should not use Tadalafil 40mg, as safety in women is unestablished.
  • Always inform your healthcare provider about all medications you are taking.

If unavoidable, reduce CYP3A substrate dose according to product labeling.

  • Tadalafil 40mg is a potent PDE5 inhibitor used for specific medical needs.
  • Check expiration date before using to ensure medication efficacy.
  • Avoid taking Tadalafil 40mg with fatty meals if concerned about absorption.
  • Lifestyle modifications can enhance the effectiveness of Tadalafil treatment.
  • Combination therapy with other ED drugs is not usually recommended.
  • Contact emergency services if you experience symptoms of a heart attack.

tucatinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Contraindications for Tadalafil

erythromycin base will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin ethylsuccinate will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin lactobionate will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin stearateerythromycin stearate will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin stearate will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Pregnancy Categories

fexinidazolefexinidazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration may increase risk for adverse effects of CYP3A4 substrates. fexinidazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosamprenavirfosamprenavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosamprenavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. acebutololtadalafil increases effects of acebutolol by pharmacodynamic synergism.

Product Dosage Quantity + Bonus Price
Cialis Generic40mg10 Pills37.79€ 35.99€
Cialis Generic60mg10 Pills41.22€ 39.26€
Tadalista Super Active20mg180 + 20 Pills521.59€ 496.75€
Cialis Generic20mg90 + 6 Pills154.71€ 147.34€
Cialis Generic60mg270 + 10 Pills443.96€ 422.82€
Cialis Generic20mg10 Pills31.49€ 29.99€
Cialis Generic60mg360 + 10 Pills570.52€ 543.35€
Cialis Generic2.5mg120 + 6 Pills128.93€ 122.79€
Cialis Generic2.5mg270 + 10 Pills199.64€ 190.13€
Cialis Generic40mg20 Pills59.47€ 56.64€
Tadalista Super Active20mg90 + 10 Pills314.14€ 299.18€
Cialis Generic40mg180 + 10 Pills277.29€ 264.09€
Cialis Generic60mg120 + 8 Pills240.18€ 228.74€
Cialis Generic40mg270 + 10 Pills382.19€ 363.99€
Cialis Generic2.5mg180 + 10 Pills154.86€ 147.49€
Cialis Generic2.5mg30 + 4 Pills51.95€ 49.48€
Cialis Generic10mg270 + 10 Pills308.71€ 294.01€

tadalafil increases effects of acebutolol by pharmacodynamic synergism.

Administration Instructions for Tadalafil

Use of nitroglycerin within a few days of PDE5 inhibitors is contraindicated. PDE5 inhibitors have been shown to potentiate the hypotensive effects of organic nitrates. tadalafil increases effects of nitroglycerin rectal by additive vasodilation. Either increases effects of the other by additive vasodilation. Coadministration of PDE-5 inhibitors (eg, avanafil, sildenafil, tadalafil, vardenafil) and guanylate cyclase stimulators (eg, riociguat) is contraindicated due to risk of additive hypotension; do not administer 24 hr before or within 48hr of each other.

Serious Tadalafil Side Effects (Occurring in less than 1 in 1,000 people)

Either increases effects of the other by pharmacodynamic synergism. Coadministration of vericiguat with PDE-5 inhibitors may result in additive hypotensive effects. apalutamideapalutamide will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration of apalutamide, a strong CYP3A4 inducer, with drugs that are CYP3A4 substrates can result in lower exposure to these medications. Avoid or substitute another drug for these medications when possible. acetazolamidetadalafil increases effects of acetazolamide by pharmacodynamic synergism.

2.2 Dose Adjustment in Renal Impairment

Avoid concurrent use of tadalafil for pulmonary HTN in patients taking strong CYP3A4 inhibitors. clarithromycin will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. cobicistatcobicistat will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Adjust tadalafil dose for PAH; if on cobicistat, start tadalafil 20 mg/day and may increase up to 40 mg/day; avoid tadalafil when starting cobicistat; for ED, may take a single dose of tadalafil not exceeding 10 mg in 72 hr. cobicistat will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Can you skip a day of tadalafil daily?

darunavirdarunavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. darunavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. enzalutamideenzalutamide will decrease tadalafil 10mg daily the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. enzalutamide will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. erythromycin baseerythromycin base will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tadalafil increases effects of acetazolamide by pharmacodynamic synergism.

Contraindication Explanation Alternative Actions
Nitrates use Can cause severe hypotension Consult doctor for alternatives
Severe liver impairment Reduced drug clearance Adjust dose or avoid
Recent stroke or heart attack Risk of adverse cardiovascular events Monitor closely
Hypotension Blood pressure too low Treat underlying causes

alfuzosintadalafil increases effects of alfuzosin by pharmacodynamic synergism.

Population Typical Dose Range Notes
General adult males 20mg - 40mg Adjust based on response and tolerance
Elderly Usually lower dose Due to potential liver and kidney function changes
Patients with hepatic impairment Usually start at lower doses Monitor response closely
Patients with renal impairment Dose adjustment may be necessary Depends on severity

tadalafil increases effects of alfuzosin by pharmacodynamic synergism. aliskirentadalafil increases effects of aliskiren by pharmacodynamic synergism.

Regulatory Documentation Provided

levoketoconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lonafarniblonafarnib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If coadministration unavoidable, monitor for adverse reactions and reduce CYP3A substrate dose in accordance with product labeling. lonafarnib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lopinavirlopinavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Dosing Modifications

lopinavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. nelfinavirnelfinavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. nelfinavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. nicardipinenicardipine will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. nicardipine will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. tadalafil increases effects of aliskiren by pharmacodynamic synergism.

Pregnancy & Lactation

Avoid coadministration if tadalafil used for pulmonary arterial hpertension. Reduce tadalafil dose if used for erectile dysfunction. nirmatrelvir/ritonavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ritonavirritonavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ritonavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

3. Do you take other medications?

tovorafenibtovorafenib will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration of tovorafenib (a weak CYP3A4 inducer) with CYP3A substrates where minimal concentration changes may lead to serious therapeutic failures. If unavoidable, monitor patients for loss of efficacy unless otherwise recommended in the CYP3A4 substrate prescribing information. tovorafenib will decrease the level or effect of tadalafil by affecting 10mg tadalafil hepatic/intestinal enzyme CYP3A4 metabolism. tucatinibtucatinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor blood pressure response to phosphodiesterase type 5 (PDE5) inhibitors in patients receiving concurrent blood pressure lowering therapy.

Parameter Value Notes
Absorption Rate Rapid, peak in 2 hours Taken with or without food
Half-Life Approx. 17.5 hours Influences dosing frequency
Bioavailability About 80% Amount reaching systemic circulation
Metabolism Liver, mainly via CYP3A4 Affects drug interactions
Excretion Feces (61%), Urine (36%) Metabolites excreted

amiloridetadalafil increases effects of amiloride by pharmacodynamic synergism.

2.4 Dose Adjustment for Use with Ritonavir

Evaluate for loss of therapeutic effect if medication must be coadministered. Adjust dose according to prescribing information if needed. apalutamide will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. atazanaviratazanavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stop tadalafil >24 hours prior to protease inhibitor (PI) initiation, restart 7 days after PI initiation at 20 mg once daily, and increase to 40 mg once daily based on tolerability.

Other Medical Problems

atazanavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinibceritinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ceritinib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. clarithromycinclarithromycin will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. For ED limit tadalafil to max of 2.5 mg/day (for daily use) or 10 mg dose every 72 hr (for use as needed). tadalafil increases effects of amiloride by pharmacodynamic synergism.

Top 20 Export Markets

idelalisibidelalisib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Idelalisib is a strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A substrates idelalisib will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. itraconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ketoconazoleketoconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP3A4 inhibitors may reduce tadalafil clearance increasing systemic exposure to tadalafil; significantly increased levels may result in significant adverse events including severe hypotension, syncope, visual changes, and priapism.

Side effects of taking Tadalafil 40mg Tablets

ketoconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lenacapavirlenacapavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Refer to the prescribing information of PDE5 inhibitors erectile dysfunction pills tadalafil for dose recommendations. lenacapavir will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. levoketoconazolelevoketoconazole will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. amiodaroneamiodarone will increase the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. CYP3A4 inhibitors may reduce tadalafil clearance increasing systemic exposure to tadalafil; increased levels may result in increased associated adverse events.